Literature DB >> 26299274

Treatment of Super-Refractory Status Epilepticus.

Ahmad Bayrlee1, Nimalya Ganeshalingam, Lisa Kurczewski, Gretchen M Brophy.   

Abstract

Super-refractory status epilepticus (SRSE) is a devastating neurological condition with limited treatment options. We conducted an extensive literature search to identify and summarize the therapeutic options for SRSE. The search mainly resulted in case reports of various pharmacologic and non-pharmacologic treatments. The success rate of each of the following agents, ketamine, inhaled anesthetics, intravenous immunoglobulin G (IVIG), IV steroids, ketogenic diet, hypothermia, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and vagal nerve stimulation (VNS), are discussed in greater detail. The choice of appropriate treatment options for a given patient is based on clinical presentation. This review focuses on evidence-based, pharmacotherapeutic strategies for patients in SRSE.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26299274     DOI： 10.1007/s11910-015-0589-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  60 in total

Review 1.  Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua.

Authors:  Oscar G Morales; Michael E Henry; Mitchell S Nobler; Eric M Wassermann; Sarah H Lisanby
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2005-01

Review 2.  Novel anesthetics and other treatment strategies for refractory status epilepticus.

Authors:  Andrea O Rossetti
Journal:  Epilepsia       Date:  2009-12       Impact factor: 5.864

Review 3.  VNS for refractory status epilepticus.

Authors:  F A Zeiler; K J Zeiler; J Teitelbaum; L M Gillman; M West
Journal:  Epilepsy Res       Date:  2015-03-09       Impact factor: 3.045

Review 4.  Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review.

Authors:  Marcio Versiani; Elie Cheniaux; J Landeira-Fernandez
Journal:  J ECT       Date:  2011-06       Impact factor: 3.635

Review 5.  The mechanism of action of vagus nerve stimulation for refractory epilepsy: the current status.

Authors:  K Vonck; K Van Laere; S Dedeurwaerdere; J Caemaert; J De Reuck; P Boon
Journal:  J Clin Neurophysiol       Date:  2001-09       Impact factor: 2.177

6.  Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.

Authors:  Claire R E Gall; Odai Jumma; Rajiv Mohanraj
Journal:  Seizure       Date:  2013-01-18       Impact factor: 3.184

7.  The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus.

Authors:  Courtney J Wusthoff; Sarah M Kranick; James F Morley; A G Christina Bergqvist
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

8.  Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.

Authors:  J Miró; M Toledo; E Santamarina; A C Ricciardi; V Villanueva; A Pato; J Ruiz; R Juvany; M Falip
Journal:  Seizure       Date:  2012-11-03       Impact factor: 3.184

9.  Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?

Authors:  Daniel J Costello; Ronan D Kilbride; Andrew J Cole
Journal:  J Neurol Sci       Date:  2008-11-17       Impact factor: 3.181

10.  Efficacy and safety of ketamine in refractory status epilepticus in children.

Authors:  Anna Rosati; Manuela L'Erario; Lucrezia Ilvento; Costanza Cecchi; Tiziana Pisano; Lorenzo Mirabile; Renzo Guerrini
Journal:  Neurology       Date:  2012-11-28       Impact factor: 9.910
View more
  9 in total

1.  Treatment of Convulsive Status Epilepticus.

Authors:  Eric H Grover; Yara Nazzal; Lawrence J Hirsch
Journal:  Curr Treat Options Neurol       Date:  2016-03       Impact factor: 3.598

Review 2.  What's new in refractory status epilepticus?

Authors:  Stephane Legriel; Mauro Oddo; Gretchen M Brophy
Journal:  Intensive Care Med       Date:  2016-08-20       Impact factor: 17.440

Review 3.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

4.  Successful Treatment of Super-Refractory Status Epilepticus with High-Intensity Electroconvulsive Therapy - A Case Report and Review of the Current Literature.

Authors:  Hanna Schneegans; Henning Stetefeld; Christian Dohmen; Oezguer A Onur; Fritz-Georg Lehnhardt
Journal:  J Epilepsy Res       Date:  2019-06-30

Review 5.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

6.  Indications for Inpatient Magnetoencephalography in Children - An Institution's Experience.

Authors:  Michael W Watkins; Ekta G Shah; Michael E Funke; Stephanie Garcia-Tarodo; Manish N Shah; Nitin Tandon; Fernando Maestu; Christopher Laohathai; David I Sandberg; Jeremy Lankford; Stephen Thompson; John Mosher; Gretchen Von Allmen
Journal:  Front Hum Neurosci       Date:  2021-06-04       Impact factor: 3.169

7.  Therapeutic hypothermia for pediatric refractory status epilepticus May Ameliorate post-status epilepticus epilepsy.

Authors:  Mei-Hsin Hsu; Hsuan-Chang Kuo; Jainn-Jim Lin; Ming-Yi Chou; Ying-Jui Lin; Pi-Lien Hung
Journal:  Biomed J       Date:  2020-04-21       Impact factor: 4.910

8.  Adjunctive use of the ketogenic diet in a young adult with UBE2A deficiency syndrome and super-refractory status epilepticus.

Authors:  Christopher Martin Allen; Christiana Avye Hall; Naomi Elizabeth Cox; Hayley Ryan; Thearina De Beer; Michael Francis O'Donoghue
Journal:  Epilepsy Behav Rep       Date:  2021-05-07

9.  Treatment of Super-Refractory Status Epilepticus: A Review.

Authors:  Juan G Ochoa; Michelle Dougherty; Alex Papanastassiou; Barry Gidal; Ismail Mohamed; David G Vossler
Journal:  Epilepsy Curr       Date:  2021-03-10       Impact factor: 7.500
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.